These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 14241345)

  • 1. [CHANGES IN THE SENSITIVITY TO CHEMOTHERAPY OF MYCOBACTERIUM TUBERCULOSIS IN ANIMAL ORGANISMS].
    SOLOVEV VN; ZUEVA VS
    Probl Tuberk; 1964; 42():62-6. PubMed ID: 14241345
    [No Abstract]   [Full Text] [Related]  

  • 2. [DETERMINATION OF THE RESISTANCE OF TUBERCULOSIS BACTERIA IN THE SERIAL DILUTION TEST AND IN THE VERTICAL DIFFUSION TEST].
    KALICH R; GERLOFF W; KREBS A; SCHMIEDEL A
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1965 Jan; 129():353-69. PubMed ID: 14273020
    [No Abstract]   [Full Text] [Related]  

  • 3. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 4. [TUBERCULOUS MENINGITIS WITH RESISTANT KOCH BACILLI; RECOVERY OWING TO CYCLOSERINE-PYRAZINAMIDE COMBINATION].
    FOUQUET J; CORNU P
    Arch Fr Pediatr; 1964 Dec; 21():1217-21. PubMed ID: 14248329
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDIES ON MYCOBACTERIAL SENSITIVITY TO ANTIBIOTICS AND CHEMOTHERAPEUTIC AGENTS].
    DYKHNO MM; KOCHEMASOVA ZN; DOROZHKOVA IR
    Antibiotiki; 1963 Jul; 8():597-601. PubMed ID: 14090358
    [No Abstract]   [Full Text] [Related]  

  • 6. FURTHER OBSERVATIONS ON THE KANAMYCIN RESISTANCE IN TUBERCULOUS PATIENTS.
    TSUKAMURA M; KASAI E; TSUKAMURA S
    Jpn J Tuberc; 1964 Jul; 12():27-33. PubMed ID: 14178489
    [No Abstract]   [Full Text] [Related]  

  • 7. COMPARISON OF THE DEGREE OF DRUG RESISTANCE BETWEEN "1 PER CENT OGAWA MEDIUM" AND "LOEWENSTEIN-JENSEN MEDIUM".
    TSUKAMURA S; TSUKAMURA M
    Jpn J Tuberc; 1963 Dec; 11():44-7. PubMed ID: 14171915
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMPARISON OF A DETERMINATION OF DRUG RESISTANCE USING 1 PER CENT OGAWA MEDIUM AND LOEWENSTEIN-JENSEN MEDIUM (EXAMINATION OF SPUTUM)].
    TSUKAMURA S
    Kekkaku; 1964 Feb; 39():60-3. PubMed ID: 14136876
    [No Abstract]   [Full Text] [Related]  

  • 9. [ETHIONAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    ZIERSKI M
    G Ital Chemioter; 1963; 10():110-7. PubMed ID: 14074246
    [No Abstract]   [Full Text] [Related]  

  • 10. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 11. DRUG RESISTANCE IN PULMONARY TUBERCULOSIS; TREATMENT WITH ETHIONAMIDE IN VARIOUS DRUG COMBINATIONS.
    MEDINA G; CHAPMAN PT
    Dis Chest; 1965 Feb; 47():146-52. PubMed ID: 14261185
    [No Abstract]   [Full Text] [Related]  

  • 12. [EXPERIMENTAL STUDIES ON THE DEVELOPMENT OF DRUG RESISTANCE IN VIVO. 2. STUDIES ON THE DEVELOPMENT OF KANAMYCIN (KM) AND ETHIONAMIDE (TH) RESISTANCE IN EXPERIMENTAL TUBERCULOSIS IN MICE].
    KIMURA H
    Kekkaku; 1965 Mar; 40():95-101. PubMed ID: 14317669
    [No Abstract]   [Full Text] [Related]  

  • 13. [BRONCHIAL TUBERCULOSIS AND BACTERIAL RESISTANCE].
    PILHEU JA
    Torax; 1963; 12():163-4. PubMed ID: 14158177
    [No Abstract]   [Full Text] [Related]  

  • 14. DRUG-SENSITIVITY OF MYCOBACTERIUM BOVIS.
    HEJNY J
    Acta Tuberc Pneumol Scand; 1964; 44():195-8. PubMed ID: 14162309
    [No Abstract]   [Full Text] [Related]  

  • 15. PULMONARY TUBERCULOSIS.
    CHAVES AD
    Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE USE OF ANTIBACILLARY DRUGS].
    BERNARD E; PIERON R
    Cah Coll Med Hop Paris; 1964 Apr; 5():241-51. PubMed ID: 14146836
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE CLINICAL ASPECTS OF ATYPICAL PULMONARY MYCOBACTERIOSIS].
    ALMANSAPASTOR A
    Rev Esp Tuberc; 1964 Jan; 33():1-8. PubMed ID: 14132983
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 19. RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA; GROSS JH; GOLDHAMMER EJ
    Am Rev Respir Dis; 1964 Dec; 90():957-60. PubMed ID: 14233802
    [No Abstract]   [Full Text] [Related]  

  • 20. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. I. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF KANAMYCIN, ETHIONAMIDE AND EITHER CYCLOSERINE OR PYRAZINAMIDE.
    KASS I
    Tubercle; 1965 Jun; 46():151-65. PubMed ID: 14327963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.